BCEPS professor Kjell Arne Johansson receives NOK 12 million in new funding
The Research Council of Norway has awarded NOK 12 million to a 5-year project on "Equity and financial household impact in randomised controlled trials, implementation research and cohort studies in India" (EQUIFINANCE).
This project will be led by Kjell Arne and is a collaboration between the Bergen Centre for Ethics and Priority Setting (BCEPS), the Centre for Intervention Science in Maternal and Child Health (CISMAC) at the University of Bergen, the Centre for Health Research and Development, Society for Applied Studies (SAS) in India, and the Translational Health Science and Technology Institute (THSTI), also in India.
The main idea behind EQUIFINANCE is to develop and evaluate new methods to assess equity and economic impact (financial risk protection) of healthcare interventions on households.
Impact on equity and economic return for households of neonatal and child health interventions will be assessed in four high-quality studies:
- Community-initiated kangaroo mother care (randomised controlled trial - RCT)
- Zinc supplementation to antibiotic treatment of severe infections (randomised controlled trial - RCT)
- Integrated community case management of pneumonia (study using implementation research design)
- High-risk infant follow-up (pregnancy cohort study)
All studies will be conducted in India, and results from the trials are expected to be relevant for SDG 3.8. Extended cost-effectiveness analysis (ECEA), concentration index and curves, and CONSORT-Equity 2017 guidance will be applied and developed.